Hibernation Therapeutics Limited is an Australian unlisted public company.

All investor enquiries should be directed to Orbit Capital.

Orbit Capital is an Australian investment bank and a provider of corporate advisory services including capital raisings, IPO management and commercialization strategies. The company holds an Australian Financial Services Licence issued by the Australian Securities and Investment Commission (AFSL 230 327).

Established in May 2000 by Managing Director Gregory Baynton and ABN AMRO Morgans, Orbit Capital holds a strategic alliance with ABN AMRO Morgans, Australia’s largest retail stockbroking network.

Orbit Capital has a successful track record in private equity investment and IPOs including:

• PIPE Networks Limited IPO (2005)
  second-best performing IPO for 2005 on ASX

• Tissue Therapies Limited IPO (2004)
  a wound management & cell culture company

• Other technology-related IPOs and numerous pre-IPO equity raisings since establishment of Orbit Capital, including Alchemia, Novera Energy, Genera Biosystems and Farmacule BioIndustries.